Phathom Pharmaceuticals I... (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

3.35

-0.94 (-21.91%)

At close: May 01, 2025, 3:59 PM

3.36

0.15%

After-hours: May 01, 2025, 06:21 PM EDT

Phathom Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-334.33M	-201.59M	-197.72M	-143.88M	-129.07M	-255.13M	-1.29M
Depreciation & Amortization	795K	575K	620K	521K	323K	8K	n/a
Stock-Based Compensation	24.05M	45.02M	24.13M	16.81M	5.84M	406K	n/a
Other Working Capital	n/a	-8.97M	-3.24M	-17.68M	27.71M	-11.79M	-10K
Other Non-Cash Items	42.71M	32.06M	21M	5.41M	1.59M	131.46M	50K
Deferred Income Tax	n/a	n/a	n/a	n/a	-95K	96.27M	n/a
Change in Working Capital	n/a	-13.64M	5.44M	-27.48M	51.72M	-9.52M	215K
Operating Cash Flow	-266.77M	-137.58M	-146.53M	-148.62M	-69.69M	-36.51M	-1.02M
Capital Expenditures	n/a	-1.63M	-1.04M	-328K	-1.04M	-25.25M	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-135K	n/a	-1.18M	-330K	-1.19M	-25.12M	n/a
Investing Cash Flow	-135K	-1.63M	-1.04M	-328K	-1.04M	-25.25M	n/a
Debt Repayment	59.4M	39.32M	n/a	42.76M	25M	24.85M	1.9M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.6M	172.8M	95.45M	1.94M	629K	279.8M	2K
Financial Cash Flow	182.77M	367.58M	120.04M	44.71M	114.46M	304.65M	1.9M
Net Cash Flow	-84.13M	228.37M	-27.53M	-104.24M	43.73M	242.89M	879K
Free Cash Flow	-266.77M	-139.21M	-147.57M	-148.94M	-70.73M	-61.76M	-1.02M